NDT Advance Access published July 4, 2006

Size: px
Start display at page:

Download "NDT Advance Access published July 4, 2006"

Transcription

1 NDT Advance Access published July 4, 2006 Nephrol Dial Transplant (2006) 1 of 7 doi: /ndt/gfl339 Original Article Starting and withdrawing haemodialysis associations between nephrologists opinions, patient characteristics and practice patterns (data from the Dialysis Outcomes and Practice Patterns Study) Mark Lambie 1, Hugh C. Rayner 1, Jennifer L. Bragg-Gresham 2, Ronald L. Pisoni 2, Vittorio E. Andreucci 3, Bernard Canaud 4, Friedrich K. Port 2 and Eric W. Young 5 1 Department of Renal Medicine, Birmingham Heartlands Hospital, Birmingham, UK, 2 Arbor Research Collaborative for Health, Ann Arbor, Michigan, USA, 3 Universita Federico II, Naples, Italy, 4 Nephrology Department, Lapeyonie University Hospital, Montpellier, France and 5 Veterans Affairs Medical Centre/University of Michigan, Ann Arbor, MI, USA Abstract Background. The incidence and prevalence of haemodialysis vary widely across countries. The variation may be attributable to differences in the incidence of end-stage renal disease and/or in the availability of haemodialysis. Previous studies have identified differences in nephrologists opinions about the availability of haemodialysis and its appropriateness for patients with comorbidities. We studied the associations between nephrologists opinions, availability of haemodialysis, patient characteristics and comorbidities, and facilities withdrawal rates. Methods. Most of our analyses used data from 242 haemodialysis units in six countries (France, Germany, Italy, Spain, UK and the USA) in the first phase of the Dialysis Outcomes and Practice Patterns Study (DOPPS I). Opinions about access to and practice patterns in dialysis facilities, measured by the level of agreement with standardized statements, were collected from medical directors and nurse managers. A sub-analysis considered data from corresponding facilities in DOPPS II. Results. We found wide variations in the prevalence of waiting lists for new dialysis patients (UK 60%; USA 25%; Germany 0%; P < 0.05), in agreement with starting haemodialysis for patients with advanced age, dementia and comorbidities (UK, France < USA < other countries; P < 0.05), and in agreement with withdrawing dialysis (other countries < UK/USA; P < 0.05). The estimated glomerular filtration rate at the start of dialysis was not significantly different in units with waiting lists. Significant associations were found between nephrologists opinions and the odds of patients being 80 years old, and between Correspondence and offprint requests to: Friedrich K. Port, MD, Arbor Research Collaborative for Health, 315 W. Huron, Suite 360, Ann Arbor, MI 48103, USA. friedrich.port@arborresearch.org opinions and the rate and relative risk of withdrawal of haemodialysis. No significant associations were found between opinions and patients comorbidities or dependency. Conclusion. Differences within and across countries in nephrologists opinions regarding starting and withdrawing haemodialysis reflect differences in access to haemodialysis and the practice of withdrawal of haemodialysis in their facilities. Keywords: access to haemodialysis; Dialysis Outcomes and Practice Patterns Study (DOPPS); end-stage renal disease; practice patterns; withdrawal of dialysis Introduction There is wide variation across countries in the number of end-stage renal disease (ESRD) patients starting haemodialysis (HD) [1 5]. In 1998, the US had an incidence of 310 dialysis patients per million population, compared with 77 per million in the UK, 148 per million in Germany and 104 per million in Italy [5]. This discrepancy may be due to differences in (a) the incidence of ESRD in each country, (b) the availability of haemodialysis facilities, (c) the willingness of patients and their families to accept this type of treatment and (d) the criteria used by nephrologists to decide whether or not to offer dialysis to individual patients. Surveys of nephrologists opinions regarding the suitability of certain patients for dialysis have shown variations both within and across countries [6,7]. For example, in a 1996 survey, nephrologists in the UK and Canada were significantly less likely than nephrologists in the USA to consider dialysis for patients with significant comorbidities, particularly dementia [7]. As yet, no study has reported on whether these differences ß The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please journals.permissions@oxfordjournals.org

2 2of7 are associated with differences in the characteristics of patients starting HD in the facilities in which the nephrologists practice. Rates of withdrawal of patients from dialysis have also been shown to vary across countries and across dialysis facilities [8 13]. Differences in rates of withdrawal may result from variations in (a) the attitudes of HD patients across facilities, (b) patient comorbidities and (c) the practices of the doctors and nurses who care for dialysis patients [6]. The Dialysis Outcomes and Practice Patterns Study (DOPPS) is an international prospective, observational study of HD practices and patient outcomes [14,15]. Using data from the DOPPS Phase I and II, our study examined the associations between nephrologists opinions about the practices of starting and withdrawing haemodialysis, the characteristics of patients receiving haemodialysis, and the practice patterns of dialysis facilities in order to better understand the relative importance of these different factors in determining the actual practice and outcomes. Subjects and methods Study design and sample The design of the DOPPS is described in detail elsewhere [14]. Data for this report were collected from 20 dialysis units each in France, Italy, Spain and the UK, 21 units in Germany, and 141 units in the USA. In the UK, data were collected from 10 centre and 10 satellite units, the satellite units not being linked to DOPPS centre units. Although DOPPS was also conducted in Japan, opinions on starting and stopping HD were not collected in Japan and therefore data from Japan are not included in this analysis. A subanalysis investigating time trends in opinions also included DOPPS II data for the corresponding facilities in DOPPS I (n ¼ 129: France ¼ 15, Germany ¼ 16, Italy ¼ 20, Spain ¼ 19, UK ¼ 17 and USA ¼ 42 facilities). Questionnaires were completed by medical directors (i.e. the physicians with managerial responsibility for the units) and nurse managers (for questions regarding withdrawing patients from dialysis). Respondents were asked to indicate their level of agreement or disagreement with a series of statements about their practice. Statements were related to the service provided by the unit in the study, not the whole department. Statements were standardized and translated into local languages to allow direct comparison of opinions across countries. The units were selected at random and were stratified geographically to provide a representative sample of all units in each country. Responses from units in DOPPS I were gathered from May 1998 to October Responses from units in DOPPS II were collected between 2002 and 2004 using the same methodology. Statements in the questionnaire are shown in Table 1. To assess the relationship between nephrologists opinions and practice patterns in their units, we correlated the medical directors opinions with related patient characteristics among patients who were new started dialysis within 90 days of the start of the study to the unit. We divided and analysed the nephrologists opinions in two ways: (i) agreed vs disagreed þ neutrals, and (ii) agreed vs disagreed (excluding neutrals). Statistical analyses M. Lambie et al. Responses to statements were categorized as follows: strongly disagree, disagree, neither agree nor disagree, agree or strongly agree. A summary score was calculated for each country by multiplying the percentage of responses in each category by 100 for strongly disagree, 50 for disagree, by 0 for neither disagree nor agree (neutral), þ50 for agree and þ100 for strongly agree. Hence, summary scores range from þ100 if all units strongly agree to 100 if all units strongly disagree. A score of 0 indicates either that all of the individual units are neutral (neither agree nor disagree) or that the scores of the units that agree balance the scores of the units that disagree. The glomerular filtration rate (GFR) was calculated using the five-variable Modification of Diet in Renal Disease formula for incident patients (entering the study within 7 days of first-ever HD treatment) who had laboratory data available from before their first-ever dialysis session [16]. These data were available for 40% of the patients and were summarized at the facility level for the analysis. All analyses were performed using the SAS software, Version 9.1 (SAS Institute; Cary, North Carolina, USA). Simple means were calculated by country. Significant differences across countries in levels of agreement were tested Table 1. Statements about practices regarding the initiation and withdrawal of HD (1) We attempt to initiate dialysis on almost every patient with advanced renal failure, regardless of age, other medical problems or degree of independence. (2) We do not start dialysis treatments on patients who are very elderly. (3) We do not start dialysis treatments on patients with multiple active and serious medical problems. (4) We do not start dialysis treatments on patients who are demented but otherwise healthy. (5) We do not start dialysis treatments on patients who live in nursing homes or are otherwise not living independently. (6) Once a patient has started dialysis in our unit, we do not encourage or facilitate withdrawal from dialysis treatments. (7) We are willing to allow patients on dialysis to withdraw from dialysis treatment if they desire. (8) Estimate the percentage of patients treated with other dialysis modalities (e.g. peritoneal dialysis) due to unavailability of haemodialysis units. (9) Estimate the percentage of patients for whom you delay initiation of haemodialysis because of unavailability of haemodialysis units. (10) Is there a waiting list for new patients trying to transfer to your unit? Note: Medical directors were asked to respond to these statements by ranking their level of agreement as strongly agree, agree, neutral (neither agree nor disagree), disagree or strongly disagree. In addition, nurse-managers were included as respondents regarding statements on withdrawal from dialysis treatment.

3 Access to haemodialysis opinions and practice 3 of 7 using t-tests, while the percentages were compared using chisquare tests. Linear mixed and logistic models were used to examine the associations between nephrologists opinions about starting patients on HD and characteristics of actual patients who entered the study within 90 days of first ever dialysis treatment. A linear model was used to look at associations with the continuous variable, age, while logistic regression was used to examine the relationships between opinions and dichotomized patient characteristics. Both types of models accounted for facility clustering. Cox proportional-hazards models were used to look at associations between opinions about withdrawal of dialysis and the actual risk of withdrawal. The sandwich estimator was used to account for facility clustering. Models were adjusted for age, sex, race, and 14 summary comorbid conditions. The United States was chosen as the reference country because it fell in the middle of the range of responses for many questions and had the largest sample size. Results To explore opinions about the availability of HD treatment, medical directors were asked if they had a waiting list for new patients waiting to transfer to their unit. Table 2 shows that significantly more renal units in the UK than in the other countries reported having a waiting list for new patients; no units in Germany reported having a waiting list. The presence of a waiting list in a dialysis unit was not associated with a lower level of renal function at the first HD treatment (unadjusted mean GFR for units with waiting list ¼ 11.1 ml/min/1.73m 2, without waiting Table 2. Medical directors perception of the impact of the availability of HD resources on treatment Country Units with waiting list for new patients (%) Patients for whom you delay starting HD due to unavailability of HD facilities mean (%, range) list ¼ 10.7 ml/min/1.73m 2 ; difference in mean adjusted for facility clustering ¼ 0.5 ml/min/1.73m 2, P ¼ 0.22). Estimates of the percentage of patients for whom the start of HD is delayed or who receive another dialysis modality because HD facilities were not available were also higher in the UK, and to a lesser extent in France and the USA (Table 2). There were significant differences between countries in the summary scores of medical directors opinions regarding their facility s practice of starting dialysis in various categories of patients. The majority of medical directors in the UK disagreed or strongly disagreed (mean score of 48, in a range from 100, meaning strongly disagree, to þ100, meaning strongly agree) with the general statement, We attempt to initiate dialysis on almost every patient with advanced renal failure, regardless of age, other medical problems, or degree of independence. In contrast, the medical directors in the USA were neutral (score of 6), those in France tended to agree (score of 33), and those in other countries agreed more strongly (scores of þ 50 in Germany, þ48 in Italy and þ55 in Spain). A slightly different pattern was observed with specific questions (Table 3). Medical directors in France and the UK were least likely to start dialysis in patients with advanced renal failure and dementia or in patients with multiple active and serious medical problems. There were no significant differences between the DOPPS I and DOPPS II data (data not shown). More medical directors in the UK than in the other countries responded that they did not start HD for patients who lived in nursing homes (or who France (0 10) 5.5 (0 50)* Germany 0 0 (0 0) 0 (0 0) Italy 10 0 (0 0) 2.2 (0 22) Spain 20 0 (0 0) 0 (0 0) UK 60* 18.1 (0 80)* 10.3 (0 50)* US (0 20) 1.6 (0 51) Patients treated with other dialysis modalities (e.g. peritoneal dialysis) due to unavailability of HD facilities mean (%, range) *P < 0.05 vs USA. Table 3. Medical directors level of agreement with practices related to initiating haemodialysis Opinion Level of agreement France Germany Italy Spain UK US We do not start HD for patients who: Are demented but otherwise healthy 23* * 32 Have multiple medical problems 15* * 48 Are not independent (nursing home) * 59 Are very elderly * 61 *P < 0.05 vs USA. Values can range from 100, meaning strongly disagree, to þ100, meaning strongly agree.

4 4of7 Table 4. Medical directors opinions correlated with patient demographics M. Lambie et al. Opinion Outcome in incident patients* in facilities with medical directors who agree P-value We do not start dialysis treatment on: Patients who are very elderly (3.3% agree/96.7% neutral or disagree) Patients who are demented, but otherwise healthy (21.9% agree/78.1% neutral or disagree) Patients who live in nursing home or are not independent (4.1% agree/95.9% neutral or disagree) Patients with multiple medical problems (8.3% agree/91.7% neutral or disagree) OR (patient 80 years) ¼ OR (patient with history of dementia) y ¼ OR (patients in nursing home or who are unable to feed themselves) ¼ 1.80 OR [patient has 6 summary comorbid conditions (out of 14)] ¼ *Incident patients defined as entering the DOPPS study within 90 days of their first ever dialysis treatment. y Adjusted for 13 comorbid conditions (excludes neurological disease). All models account for facility clustering. Table 5. Level of agreement with withdrawing and not withdrawing patients from dialysis (medical directors and nurse-managers) Opinion France Germany Italy Spain UK USA Willing to allow patients to withdraw from dialysis Medical directors 33* 52 3* 43* Nurse-managers 8* 33* 20* 18* Do not encourage or facilitate withdrawal from dialysis Medical directors 30* 33* 58* 5* Nurse managers 58* 45* 55* *P < 0.05 vs USA. Values can range from 100, meaning strongly disagree, to þ100, meaning strongly agree. were otherwise not living independently) or for very elderly patients with no other major comorbidity. The percentage of patients who started dialysis within 90 days of being enrolled in the DOPPS and who were living in a nursing home or were unable to eat independently at the time of enrolment was much higher in the USA (11.6%) than in France (1.3%), Germany (6.4%), Italy (4.7%), Spain (2.0%) and the UK (1.5%). To investigate how closely medical directors opinions reflected actual practice, we analysed associations between medical directors opinions and characteristics of patients starting dialysis in each medical director s facility (Table 4). The odds of incident patients being 80 in facilities in which medical directors said that they did not start dialysis in very elderly patients were significantly lower than the odds in other facilities (odds ratio ¼ 0.61, P ¼ 0.03). Similarly, the mean age of patients in units that favoured dialysis for the elderly was 2.9 years older than in other units (P ¼ 0.14). The odds of incident patients having a history of dementia, living in a nursing home, being unable to eat independently or having 6 summary comorbid conditions were not significantly different in those facilities in which the medical directors agreed with the statements about not starting dialysis in such patients. More medical directors than nurse managers in every country agreed that they allowed withdrawal from dialysis if a patient wished to withdraw (Table 5). Similarly, more nurse managers than medical directors responded that they did not encourage or facilitate withdrawal from dialysis. There were also significant differences between countries; agreement with withdrawal was most common in the UK and the USA. Again, there were no significant differences between the DOPPS I and DOPPS II data. The rate of withdrawal was lower in units in which medical directors agreed that they did not encourage withdrawal (0.8 withdrawals/100 patient years) than in units in which medical directors were neutral or disagreed (1.4 withdrawals/100 patient years) (Table 6). The relative risk of patients having HD withdrawn was significantly lower if the medical directors said that they did not encourage withdrawal (RR ¼ 0.55, P ¼ 0.04). Similarly, there was a higher withdrawal rate (1.3 withdrawals/100 patient years) and a significantly increased relative risk of HD withdrawal [relative risk (RR ¼ 2.22, P ¼ 0.009)] if the medical directors agreed with allowing withdrawal at the patient s request than if they were neutral or did not agree (0.6 withdrawals/100 patient years; reference group). When neutral responders were excluded from the analysis, very similar results were obtained. Discussion By using a standard questionnaire translated into the local language and applied to a random sample

5 Access to haemodialysis opinions and practice 5 of 7 Table 6. Rates of withdrawal from haemodialysis at facilities, by medical director opinions Opinion Crude rates from all census patients Relative risk of withdrawal Withdrawals Patient years Withdrawals/ 100 patient years Unadjusted Adjusted* Do not encourage or facilitate withdrawal P P Agree , Neutral/do not agree , reference 1.00 reference Allow withdrawal if patient wants Agree , Neutral/do not agree 32 5, reference 1.00 reference *Adjusted for age, sex, race and diabetes status. of HD units, DOPPS is able to describe nationally representative HD practice patterns. Differences across countries in nephrologists opinions regarding which patients would usually receive HD have previously been reported from the USA, Canada and the UK [7]. This study extends these data to other European countries, examines the associations between nephrologists views of the practice patterns within their facilities and the number and characteristics of patients starting and withdrawing from HD, and surveys pressures on HD units. In this study, nephrologists in France, the UK and the USA reported an apparent inadequacy of HD capacity; facilities in these countries were more likely to operate a waiting list for new patients and to perceive delays in the initiation of HD. Also, nephrologists in these countries more frequently reported that patients started other dialysis modalities, such as peritoneal dialysis (PD), because HD was unavailable. HD capacity is affected by the supply of, and attitudes towards, other modalities. Studies examining nephrologists attitudes towards PD suggest that there is agreement that PD rates ideally should be between 29 and 38% [17 20], although in 2002, the PD rates were 27% in the UK, compared with 10% in Spain, 8% in the USA and Italy, and 5% in Germany [4]. Supply vs demand may be more important in determining the balance between PD and HD. Transplantation rates also vary widely [21]. Deceased donor rates vary from 24.4 per million population in the UK to 29.2 in Italy, 40.9 in France and 50.6 in Spain. Living donor rates (and therefore pre-emptive rates) also vary from 1.6 per million population in Spain to 2.7 in France, 2.6 in Italy, 7.8 in the UK and 21 in the USA. This variation will affect the pressure on HD units, although there is no consistent pattern in its impact across different countries. The presence of a waiting list in a dialysis facility was not associated with a lower GFR in those patients initiating HD. This suggests that waiting lists are managed such that when dialysis is started, it is timed according to the clinical severity of the renal failure. An alternative explanation for this finding could be that a difference in opinion exists between units with and without waiting lists regarding the optimum time for dialysis initiation, as variations in attitudes do exist [22]. There were significant differences across countries in nephrologists opinions about starting HD for different categories of patients (Table 3). Agreement with not starting dialysis in very elderly patients was associated with a lower mean age of incident patients and a significantly lower odds ratio for incident patients 80 years old and older. Agreement with not starting dialysis in very elderly patients was highest in the UK and is consistent with the lower age of incident patients in the UK when compared with the other European countries [23]. The percentage of incident patients living in nursing homes or being unable to eat independently was much higher in the USA than in the European countries. However, there was no difference between the views of nephrologists in the USA and in European countries other than the UK about starting dialysis in such patients. There was also no significant association between the medical directors opinions and the odds of incident patients in their facilities who were very dependent or having multiple comorbidities. This suggests that in the USA, many more patients who are very dependent or who are living in nursing homes are referred to nephrologists for consideration for dialysis. In contrast, in Europe, non-specialists make decisions about dialysis and fewer such patients are referred [24]. This study has a number of limitations that may have led to the lack of a significant result for patient comorbidity. First, the sample size of 242 nephrologists may be too small to reveal weak associations; for example, only a small percentage of nephrologists responded that they did not start dialysis in certain categories of patients. Also, the opinions expressed apply only to a small proportion of all patients starting dialysis, which may reduce the reliability of the study. Second, differences in the selection of patients who are referred to nephrologists may cause a confounding effect. Non-specialists consider dialysis to be inappropriate for more patients than nephrologists do [24], and nephrologists opinions and practice can affect only those ESRD patients who are referred

6 6of7 to them. Third, the incident population studied may have started dialysis up to 90 days prior to enrolment in the study and may have changed their place of residence (and therefore their dialysis unit) during this time, thus weakening the association. Finally, the opinions expressed might reflect nephrologists individual opinions and practice, but not those of the other clinicians in their facility. The medical directors completing the questionnaire were specifically asked to base their responses on facility practice as a whole, but this request may have proved difficult to fulfill. Furthermore, the opinions may reflect ideal rather than actual practice. Various non-clinical factors have been shown to affect physicians decisions in other specialities [25,26]; similarly, when nephrologists make decisions about starting dialysis, they may be influenced by patients, relatives and nursing staff. There was wide variation across countries in opinions about the withdrawal of dialysis treatment. Previous studies have shown higher withdrawal rates in the USA, the UK and France (6 44%) than in Italy (up to 1.1%) [8 13]. Decisions regarding withdrawal of treatment are strongly influenced by ethical, religious and legal factors that vary across countries and cultures. It is also possible that pressure on the availability of dialysis facilities for new patients may influence decisions to minimize the duration of poor quality of life of patients currently on dialysis. The statistically significant associations between nephrologists opinions regarding the withdrawal of dialysis and the rates and risk of withdrawal indicate that these opinions do reflect facility practices. In all countries, nephrologists were more willing than nurses to encourage or facilitate withdrawal. This may reflect the closer relationship that often develops between patients and their nurses. Conclusion In agreement with reported wide variations across countries in the incidence rate of treated ESRD, this study demonstrates wide variation within and between countries in nephrologists opinions regarding the starting of HD in certain categories of patients. Opinions regarding the withdrawal of HD treatment also varied widely. The differences in nephrologists opinions are associated with actual differences in incidence rates of very elderly patients starting dialysis and in the practice of withdrawal of HD within dialysis facilities. These results suggest that the incidence rates for HD treatment are affected not just by the incidence of advanced kidney failure, but also by dialysis facility practices. Acknowledgements. The Dialysis Outcomes and Practice Patterns Study is supported by a research grant from Amgen without restrictions on publications. Conflict of interest statement. None declared. References M. Lambie et al. 1. Frei U, Schober-Halstenberg H-J. Renal Replacement Therapy in Germany, Annual Report 2004/2005. QuaSi-Niere ggmbh, Berlin, Germany. 2. Postorino M, Salomone M, Rosati A. Registro Italiano di Dialisi e Trapianoto (RIDT). Preliminary Report Registro Italiano di Dialisi e Trapianoto-Societa Italiana di Nefrologia. Rome, Italy 3. Consultores en Ciencias Humanas, Unidad de Informacion de Registros de Enfermos Renales. September Sociedad Espanola de Nefrologia (SEN). Madrid, Spain 4. Ansell D et al. UK Renal Registry Report The Renal Association: London, England, US Renal Data System, USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, Moss AH, Stocking CB, Sachs GA, Siegler M. Variation in the attitudes of dialysis unit medical directors toward decisions to withhold and withdraw dialysis. J Am Soc Nephrol 1993; 4: McKenzie JK, Moss AH, Feest TG, Stocking CB, Siegler M. Dialysis decision making in Canada, the United Kingdom, and the United States. Am J Kidney Dis 1998; 31: Catalano C. Discontinuation of treatment among Italian diabetic patients treated by renal replacement therapy. Nephrol Dial Transplant 1995; 10: Catalano C, Goodship TH, Graham KA et al. Withdrawal of renal replacement therapy in Newcastle upon Tyne: Nephrol Dial Transplant 1996; 11: Birmele B, Francois M, Pengloan J et al. Death after withdrawal from dialysis: the most common cause of death in a French dialysis population. Nephrol Dial Transplant 2004; 19: Bordenave K, Tzamaloukas AH, Conneen S, Adler K, Keller LK, Murata GH. Twenty-one year mortality in a dialysis unit: changing effect of withdrawal from dialysis. ASAIO J 1998; 44: Leggat JE Jr, Bloembergen WE, Levine G, Hulbert-Shearon TE, Port FK. An analysis of risk factors for withdrawal from dialysis before death. J Am Soc Nephrol 1997; 8: Port FK, Wolfe RA, Hawthorne VM, Ferguson CW. Discontinuation of dialysis therapy as a cause of death. Am J Nephrol 1989; 9: Young EW, Goodkin D, Mapes DL et al. The Dialysis Outcomes and Practice Patterns Study (DOPPS): an international hemodialysis study. Kidney Int 2000; 57: S-74 S Goodkin DA, Mapes DL, Held PJ. The Dialysis Outcomes And Practice Patterns Study (DOPPS): how can we improve the care of hemodialysis patients? Semin Dial 2001; 14: Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: Jassal SV, Krishna G, Mallick NP, Mendelssohn DC. Attitudes of British Isles nephrologists towards dialysis modality selection: a questionnaire study. Nephrol Dial Transplant 2002; 17: Jung B, Blake PG, Mehta RL, Mendelssohn DC. Attitudes of Canadian nephrologists toward dialysis modality selection. Perit Dial Int 1999; 19: Mendelssohn DC, Mullaney SR, Jung B, Blake PG, Mehta RL. What do American nephologists think about dialysis modality selection? Am J Kidney Dis 2001; 37: Zhao LJ, Wang T. Attitudes of Chinese chief nephrologists toward dialysis modality selection. Adv Perit Dial 2003; 19:

7 Access to haemodialysis opinions and practice 7 of Collet D. Organ donation and transplant activity per million population (pmp) in Europe, Bristol: UK Transplant, Ledebo I, Kessler M, van Biesen W et al. Initiation of dialysis-opinions from an international survey: Report on the Dialysis Opinion Symposium at the ERA-EDTA Congress, 18 September 2000, Nice. Nephrol Dial Transplant 2001; 16: Rayner HC, Pisoni RL, Bommer J et al. Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004; 19: Parry RG, Crowe A, Stevens JM, Mason JC, Roderick P. Referral of elderly patients with severe renal failure: questionnaire survey of physicians. Br Med J 1996; 313: Birbeck GL, Gifford DR, Song J, Belin TR, Mittman BS, Vickrey BG. Do malpractice concerns, payment mechanisms, and attitudes influence test-ordering decisions? Neurology 2004; 62: Little P, Dorward M, Warner G, Stephens K, Senior J, Moore M. Importance of patient pressure and perceived pressure and perceived medical need for investigations, referral, and prescribing in primary care: nested observational study. Br Med J 2004; 328: 444 Received for publication: Accepted in revised form:

Original Article. Introduction

Original Article. Introduction Nephrol Dial Transplant (2004) 19: 100 107 DOI: 10.1093/ndt/gfg418 Original Article Haemodialysis prescription, adherence and nutritional indicators in five European countries: results from the Dialysis

More information

TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA

TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA & TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA 2002-2008 Halima Resić* 1, Enisa Mešić 2 1 Clinic for Hemodialysis, University of Sarajevo Clinics Centre, Bolnička 25, 71000 Sarajevo, Bosnia

More information

THE DIALYSIS OUTCOMES and Practice

THE DIALYSIS OUTCOMES and Practice The Dialysis Outcomes and Practice Patterns Study (DOPPS): Design, Data Elements, and Methodology Ronald L. Pisoni, PhD, MS, Brenda W. Gillespie, PhD, David M. Dickinson, MS, Kenneth Chen, MS, Michael

More information

NIH Public Access Author Manuscript Kidney Int. Author manuscript; available in PMC 2014 July 01.

NIH Public Access Author Manuscript Kidney Int. Author manuscript; available in PMC 2014 July 01. NIH Public Access Author Manuscript Published in final edited form as: Kidney Int. 2014 January ; 85(1):. doi:10.1038/ki.2013.252. World-wide, mortality is a high risk soon after initiation of hemodialysis

More information

Death after withdrawal from dialysis: the most common cause of death in a French dialysis population

Death after withdrawal from dialysis: the most common cause of death in a French dialysis population Nephrol Dial Transplant (2004) 19: 686 691 DOI: 10.1093/ndt/gfg606 Original Article Death after withdrawal from dialysis: the most common cause of death in a French dialysis population Be atrice Birmelé

More information

Zhao Y Y et al. Ann Intern Med 2012;156:

Zhao Y Y et al. Ann Intern Med 2012;156: Zhao Y Y et al. Ann Intern Med 2012;156:560-569 Introduction Fibrates are commonly prescribed to treat dyslipidemia An increase in serum creatinine level after use has been observed in randomized, placebocontrolled

More information

CHAPTER 9. End Stage Kidney Disease in Aotearoa/New Zealand

CHAPTER 9. End Stage Kidney Disease in Aotearoa/New Zealand CHAPTER 9 End Stage Kidney Disease in Aotearoa/New Zealand ANZDATA gratefully acknowledges the patients and their families and the clinicians who provided data, and the contributions of the Aotearoa/New

More information

Withdrawal from Dialysis: The Literature, DOPPS, and Implications for Practice

Withdrawal from Dialysis: The Literature, DOPPS, and Implications for Practice 45 Withdrawal from Dialysis: The Literature, DOPPS, and Implications for Practice Karren King, MSW, ACSW, LCSW, Kansas City, MO Summary: Withdrawal from dialysis is a common occurrence in the United States,

More information

USRDS 1997 Annual Data Report International Comparisons of ESRD Therapy. Treated ESRD Incidence Rate for Selected Countries,

USRDS 1997 Annual Data Report International Comparisons of ESRD Therapy. Treated ESRD Incidence Rate for Selected Countries, Annual Data Report International Comparisons of ESRD Therapy Chapter XII International Comparisons of ESRD Therapy Key Words: ESRD registry ESRD prevalence Dialysis modality Renal transplantation ESRD

More information

Factors associated with do not resuscitate orders and rates of withdrawal from hemodialysis in the international DOPPS

Factors associated with do not resuscitate orders and rates of withdrawal from hemodialysis in the international DOPPS Kidney International, Vol. 68 (2005), pp. 1282 1288 Factors associated with do not resuscitate orders and rates of withdrawal from hemodialysis in the international DOPPS RACHEL B. FISSELL, JENNIFER L.

More information

David C. Mendelssohn MD, FRCPC DOPPS Update 2010

David C. Mendelssohn MD, FRCPC DOPPS Update 2010 David C. Mendelssohn MD, FRCPC DOPPS Update 2010 Budapest Nephrology School August 30, 2010 Overview 1) General aspects of DOPPS 2) Facility based analysis 3) High hemoglobin 4) Coumadin use 5) Summary

More information

. Time to transplant listing is dependent on. . In 2003, 9.1% of all prevalent transplant. . Patients with diabetes mellitus are less

. Time to transplant listing is dependent on. . In 2003, 9.1% of all prevalent transplant. . Patients with diabetes mellitus are less Chapter 5: Joint Analyses with UK Transplant in England and Wales; Access to the Renal Transplant Waiting List, Time to Listing, Diabetic Access to Transplantation and the Influence of Social Deprivation

More information

Treated ESRD Incidence Rate for Selected Countries, New Patients/Million Pop. 250 USA (All) USRDS 1996

Treated ESRD Incidence Rate for Selected Countries, New Patients/Million Pop. 250 USA (All) USRDS 1996 Annual Data Report International Comparisons of ESRD Therapy Chapter XI International Comparisons of ESRD Therapy O ver the last decade a growing number of national and regional registries dealing with

More information

Meeting the Guidelines for End-of-Life Care

Meeting the Guidelines for End-of-Life Care Advances in Peritoneal Dialysis, Vol. 22, 2006 Gillian Brunier, David M.J. Naimark, Michelle A. Hladunewich Meeting the Guidelines for End-of-Life Care The number of patients initiating dialysis in most

More information

Acceptance onto dialysis guidelines: St George Hospital

Acceptance onto dialysis guidelines: St George Hospital Acceptance onto dialysis guidelines: St George Hospital The following information is a guideline to support clinicians in decision making regarding acceptance onto dialysis. A review of international guidelines

More information

Original Article. Introduction

Original Article. Introduction Nephrol Dial Transplant (2004) 19: 121 132 DOI: 10.1093/ndt/gfg458 Original Article Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis

More information

ORIGINAL RESEARCH. 224 Journal of Renal Nutrition, Vol 20, No 4 (July), 2010: pp

ORIGINAL RESEARCH. 224 Journal of Renal Nutrition, Vol 20, No 4 (July), 2010: pp ORIGINAL RESEARCH Independent and Joint Associations of Nutritional Status Indicators With Mortality Risk Among Chronic Hemodialysis Patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS)

More information

J Am Soc Nephrol 14: , 2003

J Am Soc Nephrol 14: , 2003 J Am Soc Nephrol 14: 3270 3277, 2003 Association of Comorbid Conditions and Mortality in Hemodialysis Patients in Europe, Japan, and the United States: The Dialysis Outcomes and Practice Patterns Study

More information

Gender, low Kt/V, and mortality in Japanese hemodialysis patients: Opportunities for improvement through modifiable practices

Gender, low Kt/V, and mortality in Japanese hemodialysis patients: Opportunities for improvement through modifiable practices Original Articles Gender, low Kt/V, and mortality in Japanese hemodialysis patients: Opportunities for improvement through modifiable practices Naoki KIMATA, 1 Angelo KARABOYAS, 2 Brian A. BIEBER, 2 Ronald

More information

MORTALITY IN PATIENTS ON DIALYSIS AND TRANSPLANT RECIPIENTS

MORTALITY IN PATIENTS ON DIALYSIS AND TRANSPLANT RECIPIENTS MORTALITY IN PATIENTS ON DIALYSIS AND TRANSPLANT RECIPIENTS COMPARISON OF MORTALITY IN ALL PATIENTS ON DIALYSIS, PATIENTS ON DIALYSIS AWAITING TRANSPLANTATION, AND RECIPIENTS OF A FIRST CADAVERIC TRANSPLANT

More information

IN THE LAST few decades, several important

IN THE LAST few decades, several important Anemia Management for Hemodialysis Patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) Guidelines and Dialysis Outcomes and Practice Patterns Study (DOPPS) Findings Francesco Locatelli, MD, Ronald

More information

Screening for depression in hemodialysis patients: Associations with diagnosis, treatment, and outcomes in the DOPPS

Screening for depression in hemodialysis patients: Associations with diagnosis, treatment, and outcomes in the DOPPS Kidney International, Vol. 66 (2004), pp. 2047 2053 Screening for depression in hemodialysis patients: Associations with diagnosis, treatment, and outcomes in the DOPPS ANTONIO ALBERTO LOPES, JUSTIN M.

More information

02/27/2018. What is a Physician Home Champion? What skills does a home champion need to have?

02/27/2018. What is a Physician Home Champion? What skills does a home champion need to have? HOME HEMODIALYSIS SYMPOSIUM ANNUAL DIALYSIS CONFERENCE 2018 HOW CAN WE FOSTER MORE PHYSICIAN CHAMPIONS? Joel D. Glickman, M.D. Director, Home Dialysis Programs Professor of Clinical Medicine University

More information

Chapter 12. End Stage Kidney Disease in Indigenous Peoples of Australia and Aotearoa/New Zealand. ANZDATA Registry 39th Annual Report

Chapter 12. End Stage Kidney Disease in Indigenous Peoples of Australia and Aotearoa/New Zealand. ANZDATA Registry 39th Annual Report Chapter 12 End Stage Kidney Disease in Indigenous Peoples of and Aotearoa/ 216 ANZDATA Registry 39th Annual Report Data to 31-Dec-215 Introduction In this chapter, the rates and practice patterns for end-stage

More information

Social deprivation, ethnicity and access to kidney transplantation in England and Wales. Udaya Udayaraj

Social deprivation, ethnicity and access to kidney transplantation in England and Wales. Udaya Udayaraj Social deprivation, ethnicity and access to kidney transplantation in England and Wales Udaya Udayaraj Introduction (1) Kidney transplantation Improved survival compared to remaining on dialysis Better

More information

CARE FOR CHRONIC RENAL PATIENTS ROLE OF MULTIDISCIPLINARY APPROACH ÁGNES HARIS MD PHD, ST. MARGIT HOSPITAL, BUDAPEST BUDAPEST NEPHROLOGY SCHOOL, 2017

CARE FOR CHRONIC RENAL PATIENTS ROLE OF MULTIDISCIPLINARY APPROACH ÁGNES HARIS MD PHD, ST. MARGIT HOSPITAL, BUDAPEST BUDAPEST NEPHROLOGY SCHOOL, 2017 CARE FOR CHRONIC RENAL PATIENTS ROLE OF MULTIDISCIPLINARY APPROACH ÁGNES HARIS MD PHD, ST. MARGIT HOSPITAL, BUDAPEST BUDAPEST NEPHROLOGY SCHOOL, 2017 RENEGOTIATING LIFE WITH CHRONIC KIDNEY DISEASE CONSTANTINI

More information

DOPPS and the Elderly: Implications for Nephrology Social Work Practice

DOPPS and the Elderly: Implications for Nephrology Social Work Practice 55 : Implications for Nephrology Social Work Practice Patricia M. McKevitt, ACSW, LCSW, Chromalloy American Kidney Center, Washington University, St. Louis, MO; Juergen Bommer, Department of Nephrology,

More information

Difference in practical dialysis therapy between East Asia and US/EU

Difference in practical dialysis therapy between East Asia and US/EU Difference in practical dialysis therapy between East Asia and US/EU Jer-Ming Chang. M.D., Ph.D. 1 Professor, Attending physician, Kaohsiung Medical University Hospital; 2 Secretary General, Taiwan Society

More information

21th Budapest Nephrology School Ágnes Haris, Kálmán Polner

21th Budapest Nephrology School Ágnes Haris, Kálmán Polner 21th Budapest Nephrology School Ágnes Haris, Kálmán Polner 53 years old female, -worked as computer scientist, -lived with her husband and 2 children, -in excellent financial situation. Diagnosed with

More information

Creation, cannulation and survival of arteriovenous fistulae: Data from the Dialysis Outcomes and Practice Patterns Study

Creation, cannulation and survival of arteriovenous fistulae: Data from the Dialysis Outcomes and Practice Patterns Study Kidney International, Vol. 63 (2003), pp. 323 330 Creation, cannulation and survival of arteriovenous fistulae: Data from the Dialysis Outcomes and Practice Patterns Study HUGH C. RAYNER, RONALD L. PISONI,

More information

METABOLISM AND NUTRITION WITH PD OBESITY. Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle

METABOLISM AND NUTRITION WITH PD OBESITY. Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle METABOLISM AND NUTRITION WITH PD OBESITY Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle 1 Body Size in Patients New to Dialysis United States Body Mass Index, kg/m2 33 31

More information

What Happened? 3/20/2017. Changing Lives and Making a Difference: Home Hemodialysis Stories. Brigitte Schiller, MD, FACP, FASN

What Happened? 3/20/2017. Changing Lives and Making a Difference: Home Hemodialysis Stories. Brigitte Schiller, MD, FACP, FASN Changing Lives and Making a Difference: Home Hemodialysis Stories Brigitte Schiller, MD, FACP, FASN Chief Medical Officer Satellite Healthcare What Happened? We started building centers We started peritoneal

More information

The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival

The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival ORIGINAL ARTICLE DOI: 10.3904/kjim.2009.24.1.55 The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival Seoung Gu Kim 1 and Nam Ho Kim 2 Department of Internal Medicine,

More information

CKD Conservative care and preparation for dialysis Dr Anirudh Rao Registrar, UK Renal Registry. UK Renal Registry 2013 Annual Audit Meeting

CKD Conservative care and preparation for dialysis Dr Anirudh Rao Registrar, UK Renal Registry. UK Renal Registry 2013 Annual Audit Meeting CKD Conservative care and preparation for dialysis Dr Anirudh Rao Registrar, UK Renal Registry UK Renal Registry 2013 Annual Audit Meeting Scope of the talk Background CK MAPPS EQUAL My Research Future

More information

Nephrology Dialysis Transplantation

Nephrology Dialysis Transplantation Nephrol Dial Transplant (1999) 14: 1085 1090 Dialysis and Transplantation News Nephrology Dialysis Transplantation Annual Report of the German Renal Registry 1998 Ulrich Frei1, Hans-Jürgen Schober-Halstenberg2

More information

Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5

Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5 Nephrol Dial Transplant (2007) 22: 1955 1962 doi:10.1093/ndt/gfm153 Advance Access publication 4 April 2007 Original Article Dialysis or not? A comparative survival study of patients over 75 years with

More information

AJNT. Original Article

AJNT. Original Article . 2012 May;5(2):81-6 Original Article AJNT Reaching Target Hemoglobin Level and Having a Functioning Arteriovenous Fistula Significantly Improve One Year Survival in Twice Weekly Hemodialysis Sarra Elamin

More information

Examining Facility Level Data

Examining Facility Level Data Examining Facility Level Data for the USRDS Yi Li, PhD Professor of Biostatistics, University of Michigan, Ann Arbor Director, Kidney Epidemiology and Cost Center (KECC) Co Deputy Director, United States

More information

The EQUAL study: a European study in chronic kidney disease stage 4 patients

The EQUAL study: a European study in chronic kidney disease stage 4 patients Nephrol Dial Transplant (2012) 27 (Supple 3): iii27 iii31 doi: 10.1093/ndt/gfs277 Advance Access publication 4 July 2012 Editorial Review The EQUAL study: a European study in chronic kidney disease stage

More information

Outcomes of Chronic Dialysis Patients Admitted to the Intensive Care Unit

Outcomes of Chronic Dialysis Patients Admitted to the Intensive Care Unit Outcomes of Chronic Dialysis Patients Admitted to the Intensive Care Unit Bradford Strijack,* Julie Mojica, Manish Sood,* Paul Komenda,* Joe Bueti,* Martina Reslerova,* Dan Roberts,* and Claudio Rigatto*

More information

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York 4th International Conference on Nephrology & Therapeutics September 14, 2015 Baltimore,

More information

Preservation of Veins and Timing for Vascular Access

Preservation of Veins and Timing for Vascular Access Preservation of Veins and Timing for Vascular Access Vassilis Liakopoulos, MD, PhD Department of Nephrology School of Medicine University of Thessaly Greece Hemodialysis VA A sound long-term dialysis access

More information

End Stage Kidney Disease Among Indigenous Peoples of Australia and New Zealand

End Stage Kidney Disease Among Indigenous Peoples of Australia and New Zealand Chapter 12 End Stage Kidney Disease Among Indigenous Peoples of and New Zealand 216 ANZDATA Registry 39th Annual Report Data to 31-Dec-215 Introduction In this chapter, rates of end-stage kidney disease

More information

THE CURRENT PARADIGM of thrice-weekly

THE CURRENT PARADIGM of thrice-weekly Dose of Dialysis: Key Lessons From Major Observational Studies and Clinical Trials Rajiv Saran, MD, MS, Bernard J. Canaud, MD, Thomas A. Depner, MD, Marcia L. Keen, PhD, Keith P. McCullough, MS, Mark R.

More information

Hemodiafiltration in Europe : Trends, Practices, Outcomes & Perspectives

Hemodiafiltration in Europe : Trends, Practices, Outcomes & Perspectives Hemodiafiltration in Europe : Trends, Practices, Outcomes & Perspectives Prof. Bernard Canaud Nephrology, Dialysis and Intensive Care Lapeyronie Hospital CHRU Montpellier - France Opening remarks and special

More information

The vexing problem of suboptimal initiation of dialysis: Can we do better?

The vexing problem of suboptimal initiation of dialysis: Can we do better? Budapest Nephrology School August 30, 2010 The vexing problem of suboptimal initiation of dialysis: Can we do better? David C Mendelssohn Disclosures 2007 2010 Speaker Fees: Amgen, Ortho Biotech, Genzyme,

More information

Advances in Peritoneal Dialysis, Vol. 23, 2007

Advances in Peritoneal Dialysis, Vol. 23, 2007 Advances in Peritoneal Dialysis, Vol. 23, 2007 Antonios H. Tzamaloukas, 1,2 Aideloje Onime, 1,2 Dominic S.C. Raj, 2 Glen H. Murata, 1 Dorothy J. VanderJagt, 3 Karen S. Servilla 1,2 Computation of the Dose

More information

CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND. Stephen McDonald. Matthew Jose. Kylie Hurst INDIGENOUS 12-1

CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND. Stephen McDonald. Matthew Jose. Kylie Hurst INDIGENOUS 12-1 ANZDATA Registry 213 Report INDIGENOUS END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND CHAPTER 12 Stephen McDonald Matthew Jose Kylie Hurst 213 Annual Report - 36th Edition

More information

Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments

Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments http://www.kidney-international.org & 2006 International Society of Nephrology original article Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments

More information

Transition between home dialysis modalities another piece in the jigsaw of the integrated care pathway.

Transition between home dialysis modalities another piece in the jigsaw of the integrated care pathway. Transition between home dialysis modalities another piece in the jigsaw of the integrated care pathway. Mark Lambie and Simon J Davies Health Services Research Unit, Institute for Science and Technology

More information

Comparisons between hemodialysis (HD) and peritoneal

Comparisons between hemodialysis (HD) and peritoneal Hemodialysis and Peritoneal Dialysis: Patients Assessment of Their Satisfaction with Therapy and the Impact of the Therapy on Their Lives Erika Juergensen, Diane Wuerth, Susan H. Finkelstein, Peter H.

More information

PALLIATIVE CARE FOR PATIENTS AND FAMILIES LIVING WITH CKD AND ESRD

PALLIATIVE CARE FOR PATIENTS AND FAMILIES LIVING WITH CKD AND ESRD PALLIATIVE CARE FOR PATIENTS AND FAMILIES LIVING WITH CKD AND ESRD Karen Solcher, MSN, APRN, NP-C, CNN-NP Nephrology Nurse Practitioner Stormont-Vail Health DISCLAIMER Adult population Clinical practice

More information

Original Article. Sean F. Leavey 2, Keith McCullough 1, Erwin Hecking 3, David Goodkin 4, Friedrich K. Port 2 and Eric W. Young 1,2.

Original Article. Sean F. Leavey 2, Keith McCullough 1, Erwin Hecking 3, David Goodkin 4, Friedrich K. Port 2 and Eric W. Young 1,2. Nephrol Dial Transplant (2001) 16: 2386 2394 Original Article Body mass index and mortality in healthier as compared with sicker haemodialysis patients: results from the Dialysis Outcomes and Practice

More information

An Overview on Attitudes Towards Organ Donation in Hong Kong

An Overview on Attitudes Towards Organ Donation in Hong Kong Original Article An Overview on Attitudes Towards Organ Donation in Hong Kong Beatrice Cheng, Chung-Ping Ho, 1 Shelley Ho, 2 Angela Wong 3 Background: Despite rising patient needs, transplant activities

More information

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Shannon H. Norris, BSN, RN June 6, 2018 Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality DISCUSSION: End Stage

More information

Reduced graft function (with or without dialysis) vs immediate graft function a comparison of long-term renal allograft survival

Reduced graft function (with or without dialysis) vs immediate graft function a comparison of long-term renal allograft survival Nephrol Dial Transplant (2006) 21: 2270 2274 doi:10.1093/ndt/gfl103 Advance Access publication 22 May 2006 Original Article Reduced graft function (with or without dialysis) vs immediate graft function

More information

Comparison of mortality with home hemodialysis and center hemodialysis: A national study

Comparison of mortality with home hemodialysis and center hemodialysis: A national study Kidney International, Vol. 49 (1996), pp. 1464 1470 Comparison of mortality with home hemodialysis and center hemodialysis: A national study JOHN D. WooDs, FRIEDRICH K. PORT, DAVID STANNARD, CHRISTOPHER

More information

Characteristics of Patients Initializing Peritoneal Dialysis Treatment From 2007 to 2014 Analysis From Henan Peritoneal Dialysis Registry data

Characteristics of Patients Initializing Peritoneal Dialysis Treatment From 2007 to 2014 Analysis From Henan Peritoneal Dialysis Registry data DIALYSIS Characteristics of Patients Initializing Peritoneal Dialysis Treatment From 7 to 14 Analysis From Henan Peritoneal Dialysis Registry data Xiaoxue Zhang, 1 Ying Chen, 1,2 Yamei Cai, 1 Xing Tian,

More information

Chapter 6: Mortality. Introduction 2016 USRDS ANNUAL DATA REPORT VOLUME 2 ESRD IN THE UNITED STATES

Chapter 6: Mortality. Introduction 2016 USRDS ANNUAL DATA REPORT VOLUME 2 ESRD IN THE UNITED STATES Chapter 6: Mortality In 2014, adjusted mortality rates for ESRD, dialysis, and transplant patients, were 136, 166, and 30, per 1,000 patient-years, respectively. By dialysis modality, mortality rates were

More information

New Zealand. Dialysis and Transplantation Audit

New Zealand. Dialysis and Transplantation Audit New Zealand Dialysis and Transplantation Audit Report for New Zealand Nephrology Services on behalf of the National Renal Advisory Board Grant Pidgeon Standards and Audit Subcommittee July 2012 Establishment

More information

WHEN (AND WHEN NOT) TO START DIALYSIS. Shahid Chandna, Ken Farrington

WHEN (AND WHEN NOT) TO START DIALYSIS. Shahid Chandna, Ken Farrington WHEN (AND WHEN NOT) TO START DIALYSIS Shahid Chandna, Ken Farrington Changing Perspectives Beta blockers 1980s Contraindicated in heart failure Now mainstay of therapy HRT 1990s must Now only if you have

More information

Predicting mortality after kidney transplantation: a clinical tool

Predicting mortality after kidney transplantation: a clinical tool Transplant International ISSN 0934-0874 ORIGINAL ARTICLE Predicting mortality after kidney transplantation: a clinical tool Sarbjit V. Jassal, 1,2 Douglas E. Schaubel 3 and Stanley S. A. Fenton 1,2 1 Department

More information

Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly?

Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly? Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly? Miklos Z Molnar, MD, PhD, FEBTM, FERA, FASN Associate Professor of Medicine Division of Nephrology, Department of Medicine University

More information

Mortality After Kidney Transplantation: A Comparison Between the United States and Canada

Mortality After Kidney Transplantation: A Comparison Between the United States and Canada American Journal of Transplantation 2006; 6: 109 114 Blackwell Munksgaard C 2005 The American Society of Transplantation and the American Society of Transplant Surgeons doi: 10.1111/j.1600-6143.2005.01141.x

More information

Renal Transplant Registry Report 2008

Renal Transplant Registry Report 2008 Renal Transplant Registry Report 28 Contents:. Introduction Page 2. Summary of transplant activity 27-28 Page 2 3. Graft and Patient Survival analysis 989-28 Page 3 4. Acute rejection 989-28 Page 24. Comparison

More information

Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS

Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS original article http://www.kidney-international.org & 2006 International Society of Nephrology Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in

More information

Prof. Rosanna Coppo Director of the Nephrology, Dialysis and Transplantation Department Regina Margherita Hospital Turin, Italy. Slide 1.

Prof. Rosanna Coppo Director of the Nephrology, Dialysis and Transplantation Department Regina Margherita Hospital Turin, Italy. Slide 1. ROLE OF PATHOLOGY AND CLINICAL FEATURES IN PREDICTING PROGRESSION OF IGA NEPHROPATHY: RESULTS FROM THE ERA-EDTA RESEARCH VALIGA Rosanna Coppo, Turin, Italy Chairs: François Berthoux, Saint-Etienne, France

More information

Chapter 2: Identification and Care of Patients With CKD

Chapter 2: Identification and Care of Patients With CKD Chapter 2: Identification and Care of Patients With CKD Over half of patients in the Medicare 5% sample (aged 65 and older) had at least one of three diagnosed chronic conditions chronic kidney disease

More information

FIRST RENAL REPLACEMENT

FIRST RENAL REPLACEMENT FIRST RENAL REPLACEMENT THERAPY SELECTION IN DIABETIC PATIENTS Dr Cécile Couchoud (REIN registry, France) Davide Bolignano (ERBP, Italy) European Renal Best Practice Prof. Wim Van Biesen Chairman of ERBP

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Mode of dialysis at initiation GUIDELINES

The CARI Guidelines Caring for Australians with Renal Impairment. Mode of dialysis at initiation GUIDELINES Date written: September 2004 Final submission: February 2005 Mode of dialysis at initiation GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions

More information

Chapter XII. ESRD-International comparisons. of ESRD Therapy. USRDS 1999 Annual Data Report International Comparisons of ESRD Therapy.

Chapter XII. ESRD-International comparisons. of ESRD Therapy. USRDS 1999 Annual Data Report International Comparisons of ESRD Therapy. USRDS 1999 Annual Data Report International Comparisons of ESRD Therapy Chapter XII International Comparisons of ESRD Therapy Key Words: Dialysis modality ESRD incidence ESRD-International comparisons

More information

Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access

Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access Louise Moist Associate Professor Lead Vascular Access Ontario Renal Network Schulich School of Medicine University

More information

Haemodiafiltration - the case against. Prof Peter G Kerr Professor/Director of Nephrology Monash Health

Haemodiafiltration - the case against. Prof Peter G Kerr Professor/Director of Nephrology Monash Health Haemodiafiltration - the case against Prof Peter G Kerr Professor/Director of Nephrology Monash Health Know your opposition.. Haemodiafiltration NB: pre or post-dilution What is HDF how is it different

More information

Management of End Stage Renal Disease-Bangladesh Perspective

Management of End Stage Renal Disease-Bangladesh Perspective Send Orders for Reprints to reprints@benthamscience.net 108 The Open Urology & Nephrology Journal, 2014, 7, 108-112 Management of End Stage Renal Disease-Bangladesh Perspective Harun Ur Rashid * Open Access

More information

NHS BLOOD AND TRANSPLANT KIDNEY OFFERING SCHEME WORKING GROUP ENDORSEMENT OF A NEW NATIONAL KIDNEY OFFERING SCHEME

NHS BLOOD AND TRANSPLANT KIDNEY OFFERING SCHEME WORKING GROUP ENDORSEMENT OF A NEW NATIONAL KIDNEY OFFERING SCHEME NHS BLOOD AND TRANSPLANT KIDNEY OFFERING SCHEME WORKING GROUP ENDORSEMENT OF A NEW NATIONAL KIDNEY OFFERING SCHEME INTRODUCTION 1 Three working groups were established to consider whether changes were

More information

for comorbid conditions

for comorbid conditions Kidney International, Vol. 45 (1994), pp. 1163 1169 Continuous ambulatory peritoneal dialysis and hemodialysis: Comparison of patient mortality with adjustment for comorbid conditions PHILIP J. HELD, FRIEDRICH

More information

Changing the Paradigm from Contraction of Peritoneal Dialysis Programs to Increasing Prevalent Peritoneal Dialysis Numbers

Changing the Paradigm from Contraction of Peritoneal Dialysis Programs to Increasing Prevalent Peritoneal Dialysis Numbers Advances in Peritoneal Dialysis, Vol. 29, 2013 Jennifer Cross, Andrew Davenport Changing the Paradigm from Contraction of Peritoneal Dialysis Programs to Increasing Prevalent Peritoneal Dialysis Numbers

More information

Deceased donation data in the UK. Paul Murphy National Clinical Lead for Organ Donation United Kingdom

Deceased donation data in the UK. Paul Murphy National Clinical Lead for Organ Donation United Kingdom Deceased donation data in the UK Paul Murphy National Clinical Lead for Organ Donation United Kingdom Deceased donation data in the UK And the story behind it Paul Murphy National Clinical Lead for Organ

More information

Palliative Care: European Experience

Palliative Care: European Experience Palliative Care: European Experience Edwina Brown Disclosure of Interests Baxter Healthcare speaker fees, educational grant, research grant Fresenius Medical Care speaker fees, consultancy Europe Approx

More information

Chapter 6: Predicting Future Demand in England, a Simulation Model of Renal Replacement Therapy

Chapter 6: Predicting Future Demand in England, a Simulation Model of Renal Replacement Therapy Chapter 6: Predicting Future Demand in England, a Simulation Model of Renal Replacement Therapy Dr Paul Roderick, Senior Lecturer in Public Health Medicine, Southampton University Dr Ruth Davies, Senior

More information

Chapter 2: Identification and Care of Patients With CKD

Chapter 2: Identification and Care of Patients With CKD Chapter 2: Identification and Care of Patients With Over half of patients from the Medicare 5% sample (restricted to age 65 and older) have a diagnosis of chronic kidney disease (), cardiovascular disease,

More information

Treatment Expectations and Priorities of People with MS

Treatment Expectations and Priorities of People with MS Treatment Expectations and Priorities of People with MS Prepared by Spoonful of Sugar 97 Tottenham Court Road London W1T 4TP Date: October 2017 Spoonful of Sugar 2017 Contents Executive Summary.. 3 TaP-MS

More information

KDIGO Controversies Conference on Dialysis Initiation, Modality Choice and Prescription. January 25 28, 2018 Madrid, Spain

KDIGO Controversies Conference on Dialysis Initiation, Modality Choice and Prescription. January 25 28, 2018 Madrid, Spain KDIGO Controversies Conference on Dialysis Initiation, Modality Choice and Prescription January 25 28, 2018 Madrid, Spain Kidney Disease: Improving Global Outcomes (KDIGO) is an international organization

More information

Effects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access, and Patient Outcomes

Effects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access, and Patient Outcomes Original Investigation Effects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access, and Patient Outcomes Eduardo Lacson Jr, MD, MPH, Weiling Wang, MS, Cari DeVries, Keith

More information

Because of important technologic advances achieved over

Because of important technologic advances achieved over Anemia and Heart Failure in Chronic Kidney Disease Francesco Locatelli, Pietro Pozzoni, and Lucia Del Vecchio Cardiovascular disease is mainly responsible for the poor long-term survival observed in chronic

More information

A comparison of treatment options for management of End Stage Kidney Disease in elderly patients: A systematic review protocol

A comparison of treatment options for management of End Stage Kidney Disease in elderly patients: A systematic review protocol A comparison of treatment options for management of End Stage Kidney Disease in elderly patients: A systematic review protocol Leanne Brown Master of Nursing Science (Nurse Practitioner) 1 Glenn Gardner

More information

Measure #403: Adult Kidney Disease: Referral to Hospice National Quality Strategy Domain: Patient and Caregiver-Centered Experience and Outcomes

Measure #403: Adult Kidney Disease: Referral to Hospice National Quality Strategy Domain: Patient and Caregiver-Centered Experience and Outcomes Measure #403: Adult Kidney Disease: Referral to Hospice National Quality Strategy Domain: Patient and Caregiver-Centered Experience and Outcomes 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

Is the new Mayo Clinic Quadratic (MCQ) equation useful for the estimation of glomerular filtration rate in type 2 diabetic patients?

Is the new Mayo Clinic Quadratic (MCQ) equation useful for the estimation of glomerular filtration rate in type 2 diabetic patients? Diabetes Care Publish Ahead of Print, published online October 3, 2008 The MCQ equation in DM2 patients Is the new Mayo Clinic Quadratic (MCQ) equation useful for the estimation of glomerular filtration

More information

Assisted Peritoneal Dialysis

Assisted Peritoneal Dialysis Assisted Peritoneal Dialysis BC Kidney Days Vancouver, BC Matthew Oliver MD MHS Sunnybrook Health Sciences Centre University of Toronto Oct 18, 2012 Declaration 2 Co-inventor of the Dialysis Measurement

More information

Urgent start PD: What is it, does it work, and how can we support it?

Urgent start PD: What is it, does it work, and how can we support it? Urgent start PD: What is it, does it work, and how can we support it? Micheli Bevilacqua, MD, FRCPC Nephrologist, FHA Clinical Assistant Professor, UBC Division of Nephrology Disclosures I have no conflicts

More information

USRDS UNITED STATES RENAL DATA SYSTEM

USRDS UNITED STATES RENAL DATA SYSTEM USRDS UNITED STATES RENAL DATA SYSTEM Chapter 10: Dialysis Providers In 2013, collectively the three large dialysis organizations treated 71% of patients in 67% of all dialysis units. In the Small Dialysis

More information

Economic evaluation of end stage renal disease treatment Ardine de Wit G, Ramsteijn P G, de Charro F T

Economic evaluation of end stage renal disease treatment Ardine de Wit G, Ramsteijn P G, de Charro F T Economic evaluation of end stage renal disease treatment Ardine de Wit G, Ramsteijn P G, de Charro F T Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion

More information

Canadian Organ Replacement Register Annual Report. Treatment of End-Stage Organ Failure in Canada, 2000 to 2009

Canadian Organ Replacement Register Annual Report. Treatment of End-Stage Organ Failure in Canada, 2000 to 2009 Canadian Organ Replacement Register Annual Report Treatment of End-Stage Organ Failure in Canada, 2000 to 2009 January 2011 Who We Are Established in 1994, CIHI is an independent, not-for-profit corporation

More information

Original Article Anemia management trends in patients on peritoneal dialysis in the past 10 years

Original Article Anemia management trends in patients on peritoneal dialysis in the past 10 years Int J Clin Exp Med 2015;8(10):18050-18057 www.ijcem.com /ISSN:1940-5901/IJCEM0011104 Original Article Anemia management trends in patients on peritoneal dialysis in the past 10 years Huaye Liu, Yao Yao,

More information

The CARI Guidelines Caring for Australasians with Renal Impairment. Serum phosphate GUIDELINES

The CARI Guidelines Caring for Australasians with Renal Impairment. Serum phosphate GUIDELINES Date written: August 2005 Final submission: October 2005 Author: Carmel Hawley Serum phosphate GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions

More information

Transplant Activity in the UK

Transplant Activity in the UK Transplant Activity in the UK 2006-2007 This document has been produced by the Statistics and Audit Directorate. UK Transplant August 2007 Cover pictures: Members of Glamorgan County cricket team help

More information

Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS

Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS Kidney International, Vol. 65 (2004), pp. 2335 2342 Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS RACHEL B. FISSELL, JENNIFER L. BRAGG-GRESHAM,

More information

Chapter IV. Patient Characteristics at the Start of ESRD: Data from the HCFA Medical Evidence Form

Chapter IV. Patient Characteristics at the Start of ESRD: Data from the HCFA Medical Evidence Form Annual Data Report Patient Characteristics from HCFA Medical Evidence Form Chapter IV Patient Characteristics at the Start of ESRD: Data from the HCFA Medical Evidence Form Key Words: Medical Evidence

More information

The Intact Nephron Hypothesis in Reverse: An Argument In Favor of Incremental Initiation Of Dialysis (With Residual Kidney Function)

The Intact Nephron Hypothesis in Reverse: An Argument In Favor of Incremental Initiation Of Dialysis (With Residual Kidney Function) The Intact Nephron Hypothesis in Reverse: An Argument In Favor of Incremental Initiation Of Dialysis (With Residual Kidney Function) Thomas A. Golper MD, FACP, FASN Vanderbilt University Medical Center

More information